Startups
HpVac focuses on the development of GBC-R1 as a preventive and therapeutic first-line therapy for asthma and related allergic diseases.
Summary
10
Industry
Total funding Amount
$2.4M
Fundraising History
-
Feb 01 '21 Seed$1M